Cardiovascular risk assessment in patients with a severe mental illness: a systematic review and meta-analysis

Quintí Foguet-Boreu1,2, Maria Isabel Fernandez San Martin3,4, Gemma Flores Mateo3

  • 1Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Universitat Autònoma de Barcelona, Gran Via Corts Catalanes, 587 àtic, 08007, Barcelona, Spain. qfoguet@idiapjgol.org.

BMC Psychiatry
|May 14, 2016
PubMed

Insights

Cardiovascular risk in severe mental illness (SMI) patients is not definitively higher than in the general population. While schizophrenia patients show increased risk, overall data for SMI lacks conclusive evidence for elevated cardiovascular risk.

Area of Science:

  • Psychiatry
  • Cardiology
  • Public Health

Background:

  • Patients with severe mental illness (SMI) exhibit higher cardiovascular risk (CVR) than the general population.
  • Existing research suggests CVR may not be uniformly elevated across all SMI subgroups.

Purpose of the Study:

  • To systematically review and summarize CVR scores in patients with SMI.
  • To identify differences in CVR among various SMI subgroups and compared to control populations.

Main Methods:

  • A comprehensive literature search was conducted using MEDLINE and Web of Science databases.
  • Included studies assessed CVR in SMI patients using validated tools; risk of bias was evaluated.
  • Data were pooled using standardized mean differences (SMD) with 95% confidence intervals (CI).

Main Results:

  • 35 studies involving 12,179 SMI patients and 225,951 controls were included.
  • Schizophrenia patients demonstrated higher CVR compared to depressive disorders or mixed SMI groups.
  • Overall CVR did not significantly differ between SMI patients and controls (SMD: 0.35), with high heterogeneity observed.

Conclusions:

  • Insufficient data exist to conclusively establish increased CVR in SMI patients compared to the general population, with limited evidence for schizophrenia.
  • Further research is needed to clarify CVR in diverse SMI populations.
Abstract

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
1.0K
Assessment of the Cardiovascular System II: Inspection01:29

Assessment of the Cardiovascular System II: Inspection

Inspection is the initial step in assessing the cardiovascular system. It involves a detailed visual examination that provides crucial information about a patient's circulatory and cardiac health. This systematic process, conducted from head to toe, helps identify signs of cardiovascular conditions by observing physical appearance, skin and mucous membranes, jugular and carotid pulsations, chest symmetry, and the condition of the extremities.
Head and Neck
1.1K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
653
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
643
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
429
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
443